Advancing evidence in preterm neonatal medicine

Pamela K. Donahue, Karen A Robinson

Research output: Contribution to journalArticle

Abstract

Few interventions and treatments for premature infants have undergone the rigors of a randomized controlled trial (RCT), the cornerstone of evidence-based healthcare. Multiple barriers in establishing a quality evidence base for the care of preterm infants are examined including the systematic exclusion of children from drug trials, vulnerability of the infants, burden to families of the consent process for RCTs, and the lack of standard measurements and subgroup definitions that impede systematic reviews. Delays in getting evidence into practice are highlighted, including clinician knowledge of existing evidence, attitudes about the evidence, and behavior. Landmark trials are used as examples. Finally, a call for the research community to develop guidance on good clinical research practice for preterm infants is offered that will allow the synthesis of the totality of evidence.

Original languageEnglish (US)
Pages (from-to)289-295
Number of pages7
JournalDevelopmental Disabilities Research Reviews
Volume16
Issue number4
DOIs
StatePublished - 2010

Fingerprint

Premature Infants
Medicine
Evidence-Based Practice
Research
Randomized Controlled Trials
Pharmaceutical Preparations
Therapeutics

Keywords

  • Evidence based medicine
  • Infant
  • Intensive care
  • Neonatal
  • Premature
  • Randomized controlled trials (as topic)

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Psychiatry and Mental health
  • Developmental and Educational Psychology

Cite this

Advancing evidence in preterm neonatal medicine. / Donahue, Pamela K.; Robinson, Karen A.

In: Developmental Disabilities Research Reviews, Vol. 16, No. 4, 2010, p. 289-295.

Research output: Contribution to journalArticle

@article{c391706c0930467185339fb0b383f3ce,
title = "Advancing evidence in preterm neonatal medicine",
abstract = "Few interventions and treatments for premature infants have undergone the rigors of a randomized controlled trial (RCT), the cornerstone of evidence-based healthcare. Multiple barriers in establishing a quality evidence base for the care of preterm infants are examined including the systematic exclusion of children from drug trials, vulnerability of the infants, burden to families of the consent process for RCTs, and the lack of standard measurements and subgroup definitions that impede systematic reviews. Delays in getting evidence into practice are highlighted, including clinician knowledge of existing evidence, attitudes about the evidence, and behavior. Landmark trials are used as examples. Finally, a call for the research community to develop guidance on good clinical research practice for preterm infants is offered that will allow the synthesis of the totality of evidence.",
keywords = "Evidence based medicine, Infant, Intensive care, Neonatal, Premature, Randomized controlled trials (as topic)",
author = "Donahue, {Pamela K.} and Robinson, {Karen A}",
year = "2010",
doi = "10.1002/ddrr.125",
language = "English (US)",
volume = "16",
pages = "289--295",
journal = "Mental Retardation and Developmental Disabilities Research Reviews",
issn = "1080-4013",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Advancing evidence in preterm neonatal medicine

AU - Donahue, Pamela K.

AU - Robinson, Karen A

PY - 2010

Y1 - 2010

N2 - Few interventions and treatments for premature infants have undergone the rigors of a randomized controlled trial (RCT), the cornerstone of evidence-based healthcare. Multiple barriers in establishing a quality evidence base for the care of preterm infants are examined including the systematic exclusion of children from drug trials, vulnerability of the infants, burden to families of the consent process for RCTs, and the lack of standard measurements and subgroup definitions that impede systematic reviews. Delays in getting evidence into practice are highlighted, including clinician knowledge of existing evidence, attitudes about the evidence, and behavior. Landmark trials are used as examples. Finally, a call for the research community to develop guidance on good clinical research practice for preterm infants is offered that will allow the synthesis of the totality of evidence.

AB - Few interventions and treatments for premature infants have undergone the rigors of a randomized controlled trial (RCT), the cornerstone of evidence-based healthcare. Multiple barriers in establishing a quality evidence base for the care of preterm infants are examined including the systematic exclusion of children from drug trials, vulnerability of the infants, burden to families of the consent process for RCTs, and the lack of standard measurements and subgroup definitions that impede systematic reviews. Delays in getting evidence into practice are highlighted, including clinician knowledge of existing evidence, attitudes about the evidence, and behavior. Landmark trials are used as examples. Finally, a call for the research community to develop guidance on good clinical research practice for preterm infants is offered that will allow the synthesis of the totality of evidence.

KW - Evidence based medicine

KW - Infant

KW - Intensive care

KW - Neonatal

KW - Premature

KW - Randomized controlled trials (as topic)

UR - http://www.scopus.com/inward/record.url?scp=84868117645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868117645&partnerID=8YFLogxK

U2 - 10.1002/ddrr.125

DO - 10.1002/ddrr.125

M3 - Article

C2 - 25708071

AN - SCOPUS:84868117645

VL - 16

SP - 289

EP - 295

JO - Mental Retardation and Developmental Disabilities Research Reviews

JF - Mental Retardation and Developmental Disabilities Research Reviews

SN - 1080-4013

IS - 4

ER -